Soy isoflavones: Are they useful in menopause?

Mayo Clinic Proceedings

Volumn 75, Issue 11, 2000, Pages 1174-1184

  Vincent, Ann ^a   Fitzpatrick, Lorraine A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN; DAIDZEIN; DIETHYLSTILBESTROL; EQUOL; ESTRADIOL; ESTROGEN; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LIGNAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN; SOYBEAN PROTEIN; TAMOXIFEN; TRIACYLGLYCEROL;

ADULT; AGED; BREAST CANCER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; META ANALYSIS; PHYTOTHERAPY; POSTMENOPAUSE; REVIEW; SOYBEAN; TREATMENT OUTCOME;

EID: 0033756662     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/75.11.1174     Document Type: Article

References (92)

1. Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. AnnMed. 1997;29:95-I20.
2. Mazur W. Phytoestrogen content in foods. Baillieres Clin EndocrinolMetab. 1998; 12:729-742.
3. US Department of Agriculture, Agricultural Research Service. 1999. USDA Nutrient Database for Standard Reference, Release 13. Nutrient Data Laboratory Home Page. Available at: www.nal .usda.gov/fnic/foodcomp. Accessed September 19, 2000.
4. Yokotsuka T. Soy sauce biochemistry. Adv Food Res. 1986;30: 195-329.
5. Leclercq G, Heuson JC. Physiological and pharmacological effects of estrogens in breast cancer. Biochim Biophys Acta. 1979;560: 427-455.
6. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr. 1998;68(6, suppl):1333S-1346S.
7. Axelson M, Sjovall J, Gustafsson BE, Setchell KD. Soya-a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol. 1984; 102:49-56.
8. Joannou GE, Kelly GE, Reeder AY, Waring M, Nelson C. A urinary profile study of dietary phytoestrogens: the identification and mode of metabolism of new isoflavonoids. / Steroid Biochem MolBiol. 1995:54:167-184.
9. Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med. 1995:208:40-43.
10. Setchell KD, Borriello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nulr. 1984;40:569-578.
11. Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol. 1993:45:399-405.
12. Miksicek RJ. Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med. 1995;208:44-50.
13. Kuiper CG, Carlsson B, Grandien K,et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology. 1997:138:863870.
14. Paech K, Webb P, Kuiper GG,et al. Differential ligand activation of estrogen receptors ERcx and ERβ at API sites. Science. 1997; 277:1508-1510.
15. Fitzpatrick LA. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal woman. Mayo Clin Proc. 1999;74:601-607.
16. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, Rice-Evans CA. Antioxidant activity of phytoestrogenic isoflavones. Free Radie Res. 1997:26:63-70.
17. Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med. 1995;208:124-130.
18. Mäkelä S. Chemoprevention of prostate cancer: role of plant estrogens in normal and estrogen-related growth of rodent prostate. Turun Yliopiston Julkaisuja Ann Univ Turkuenis. 1995;170(series D):l-138.
19. Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 1995;147:295-302.
20. Campbell DR, Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol. 1993:46:381-388.
21. Akiyama T, Ishida J, Nakagawa S,et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987; 262:5592-5595.
22. Adlercreutz H, Höckerstedt K, Bannwart C,et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem. 1987;27: 1135-1144.
23. Adlercreutz H, Höckerstedt K, Bannwart C, Hämäläinen E, Fotsis T, Bloigu S. Association between dietary fiber, urinary excretion of lignans and isoflavonic phytoestrogens, and plasma non-protein bound sex hormones in relation to breast cancer. In: Bresciani F, King RTB, Lippman ME, Raynaud JP, eds. Hormones and Cancer 3. New York, NY: Raven Press; 1988:409-412. Progress in Cancer Research and Therapy, vol 35.
24. Fitzpatrick LA, Litin SC, Bell MR. The Women's Health Initiative: a heart-to-HRT conversation [editorial]. Mayo Clin Proc. 2000; 75:559-561.
25. Meng QH, Lewis P, Wähälä K, Adlercreutz H, Tikkanen MJ. Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein. Biochim Biophys Acta. 1999; 1438:369-376.
26. Honore EK, Williams JK, Anthony MS, Clarkson TB. Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril. 1997;67:148-154.
27. Huff MW, Roberts DC, Carroll KK. Long-term effects of semipurified diets containing casein or soy protein isolate on atheroscle-
28. rosis and plasma lipoproteins in rabbits. Atherosclerosis. 1982;41: 327-336.
29. Anthony MS, Clarkson TB, Bullock BC, Wagner JD. Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vase Biol. 1997:17:2524-2531.
30. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 1995;333:276-282.
31. Clarkson TB, Anthony MS. Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab. 1998;12:589-604.
32. Crouse JR III, Terry JG, Morgan TM,et al. Soy protein containing isoflavones reduces plasma concentrations of lipids and lipoproteins [abstract]. Circulation. 1998;97:816. Abstract 17.
33. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998;68 (6, suppl):1375S-1379S.
34. Nestel PJ, Yamashita T, Sasahara T,et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vase Biol. 1997; 17:3392-3398.
35. Hodgson JM, Puddey IB, Beilin LJ, Mori TA, Croft KD. Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J Nutr. 1998:128:728-732.
36. Clarkson TB. Soy phytoestrogens: what will be their role in postmenopausal hormone replacement therapy? [editorial]. Menopause. 2000:7':71 -7'5.
37. Hargreaves PG, Licking EF, Sargeant P, Sage SO, Barnes MJ, Farndale RW. The tyrosine kinase inhibitors, genistein and methyl 2,5-dihydroxycinnamate, inhibit the release of (3H)arachidonate from human platelets stimulated by thrombin or collagen. Thromb Haemost. 1994;72:634-642.
38. Nakashima S, Koike T, Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2-mediated human platelet responses. Mol Pharmacol. 1991:39:475-480.
39. Ozaki Y, Yatomi Y, Jinnai Y, Kume S. Effects of genistein, a tyrosine kinase inhibitor, on platelet functions: genistein attenuates thrombin-induced Ca2+ mobilization in human platelets by affecting polyphosphoinositide turnover. Biochem Pharmacol. 1993;46: 395-403.
40. Schoene NW, Guidry CA. Dietary soy isoflavones inhibit activation of rat platelets. J Nutr Biochem. 1999; 10:421 -426.
41. Adlercreutz H, Mousavi Y, Höckerstedt K. Diet and breast cancer. AaaOncol. 1992:31:175-181.
42. Dünn JE. Cancer epidemiology in populations of the United States-with emphasis on Hawaii and California-and Japan. Cancer Res. 1975:35(11, pt 2):3240-3245.
43. Henderson MM. Nutritional aspects of breast cancer. Cancer. 1995:76(10, suppl):2053-2058.
44. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect. 1995;103(suppl 7): 103-112.
45. Martin PM, Horwitz KB, Ryan DS. McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978; 103:1860-1867.
46. Adlercreutz H. Fotsis T, Heikkinen R, el al. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet. 1982:2:1295-1299.
47. Adlercreutz H, Fotsis T, Bannwart C,et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and amicarcinogens, in urine of women on various habitual diets. J Steroid Biochem. 1986:25(5B):791-797.
48. Barnes S, Grubbs C, Setchell KD, Carlson J. Soybeans inhibit mammary tumors in models of breast cancer. Prog Clin Biol Res. 1990;347:239-253.
49. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast-cancer risk in Singapore. Lancet. 1991 ;337:11971200.
50. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun. 1991; 179:661-667.
51. Troll W, Wiesner R, Shellabarger CJ, Holtzman S, Stone JP. Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis. 1980; 1:469-472.
52. Zava DT, Bien M, Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect. 1997;105(suppl 3):637-645.
53. Wang TT, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996;17:271-275.
54. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Cynecol. 1996;87(5, pt 2):897-904.
55. Fotsis T, Pepper M, Adlercreutz H,et al. Genistein, a dietaryderived inhibitor of in vitro angiogenesis. Proc Natl Acad Sei U S A. 1993;90:2690-2694.
56. Colditz GA, Hankinson SE, Hunter DJ,et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N EnglJ Med. 1995;332:1589-1593.
57. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer [published correction appears in Lancet. 1997:350:1484]. Lancet. 1997;350: 1047-1059.
58. Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton L, Hoover R. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA. 2000;283:485-491.
59. Bush TL, Whiteman MK. Hormone replacement therapy and risk of breast cancer [editorial], JAMA. 1999;281:2140-2141.
60. Nagata C, Kabuto M, Kurisu Y, Shimizu H. Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr Cancer. 1997; 29:228-233.
61. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr. 1994;60:333-340.
62. Lu LJ, Anderson KE, Grady JJ, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 1996;5:63-70.
63. Hargreaves DF, Potten CS, Harding C,et al. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab. 1999;84:4017-4024.
64. Zheng W, Dai Q, Custer LJ,et al. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 1999:8:35-40.
65. Arjmandi BH, Alekel L, Hollis BW,et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. JNutr. 1996:126:161-167.
66. Blair HC, Jordan SE, Peterson TG, Barnes S. Variable effects of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem. 1996;61:629-637.
67. Anderson JJ, Garner SC. Phytoestrogens and bone. Bail/ieres Clin Endocrinol Metab. 1998; 12:543-557.
68. Tsutsumi N. Effect of coumestrol on bone metabolism in organ culture. Biol Pharm Bull. 1995:18:1012-1015.
69. Bonaccorsi G, Albertazzi P. Constantino D. Soy phytoestrogens and bone [abstract]. In: Program and Abstracts of the North American Menopause Society Meeting; September 2-5, 1997; Washington, DC; 44.
70. Atkinson C, Compston JE, Robins SP, Bingham SA. The effects of isoflavone phytoestrogens on bone: preliminary results from a large randomized controlled trial [abstract]. Enclocr Soc Anna Meet Program Abstr. 2000;82:43.
71. Shaywitz SE Shaywitz BA, Pugh KR,et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197-1202.
72. Simpkins JW, Singh M, Bishop J. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging. 1994;15(suppl 2):S195-S197.
73. Pan Y, Anthony M, Clarkson TB. Effect of estradiol and soy phytoestrogens on choline acetyltransferase and nerve growth factor mRNAs in the frontal cortex and hippocampus of female rats. ProcSocExpBiolMed. 1999:221:118-125.
74. Murphy DD, Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J Neurosci. 1996:16:4059-4068.
75. Clarkson TB. Can soy phytoestrogens substitute for traditional hormone replacement therapy? Menopausal Med. 1997;5:14.
76. Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr. 1998; 68(6, suppl):1413S-1417S.
77. Duncan AM, Underbill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS. Modest hormonal effects of soy isoflavones in postmenopausal women [published correction appears in J Clin Endocrinol Metab. 2000;85:448]. J Clin Endocrinol Metab. 1999:84:34793484.
78. Mesiano S, Katz SL, Lee JY, Jaffe RB. Phytoestrogens alter adrenocortical function: genistein and daidzein suppress glucocorticoid and stimulate androgen production by cultured adrenal cortical cells. J Clin Endocrinol Metab. 1999:84:24432448.
79. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS. Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab. 1999:84:192-197.
80. Brzezinski A. Adlercreutz H, Shaoul R,et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause. 1997;4:89-94.
81. Whitten PL, Naftolin F. Reproductive actions of phytoestrogens. Baillieres Clin Endocrinol Metab. 1998:12:667-690.
82. Baird DD, Umbach DM, Lansdell L,et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab. 1995;80:1685-1690.
83. Chung TK, Yip SK, Lam P, Chang AM, Haines CJ. A randomized, double-blind, placebo-controlled, crossover study on the effect of oral oestradiol on acute menopausal symptoms. Maturitas. 1996; 25:115-123.
84. Murkies AL, Lombard C, Strauss BJ, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas. 1995:21: 189-195.
85. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol. 1998;91:6-11.
86. Quella SK, Loprinzi CL, Barton DL,et al. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol. 2000;18:1068-1074.
87. Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer. 1996;25:1-7.
88. Wei H. Photoprotective action of isoflavone genistein: models, mechanisms, and relevance to clinical dermatology. J Am Acad Dermatol. 1998;39(2, pt l):271-272.
89. Kohler L, Meeuwisse G, Mortensson W. Food intake and growth of infants between six and twenty-six weeks of age on breast milk, cow's milk formula, or soy formula. Ada PaediatrScand. 1984;73: 40-48.
90. Moule GR, Braden AWH, Lamond DR. The significance of oestrogens in pasture plants in relation to animal production. Anim BreedAbstr. 1963:32:139-157.
91. Setchell KD, Gosselin SJ, Welsh MB,et al. Dietary estrogens-a probable cause of infertility and liver disease in captive cheetahs. Gastroenterology. 1987:93:225-233.
92. Leopold AS, Erwin M, Oh J, Browning B. Phytoestrogens: adverse effects on reproduction in California quail. Science. 1976:191:98100.